Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

Research output: Contribution to journalShort survey


In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.

Original languageEnglish (US)
Pages (from-to)7-9
Number of pages3
JournalCancer cell
Issue number1
StatePublished - Jul 12 2011


ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this